ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes.

Anna Vázquez-Oliver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.